title: [Progressive multifocal leukoencephalopathy and natalizumab-related immune reconstitution inflammatory syndrome: the advantage of MRI].
authors.affiliation: Service de neurologie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France.
authors.forename: N
authors.initials: N
authors.lastname: Gibelin
authors.affiliation: Service de neurologie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France; Faculté de médecine, URCA, Reims, F45, rue Cognacq-Jay, 51100 Reims, France.
authors.forename: L
authors.initials: L
authors.lastname: Daelman
authors.affiliation: Service de neurologie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France.
authors.forename: S
authors.initials: S
authors.lastname: Goulipian
authors.affiliation: Service de néphrologie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France.
authors.forename: A
authors.initials: A
authors.lastname: Wynckel
authors.affiliation: Service de neurologie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France.
authors.forename: M P
authors.initials: MP
authors.lastname: Chaunu
authors.affiliation: Service de neurologie, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France; Faculté de médecine, URCA, Reims, F45, rue Cognacq-Jay, 51100 Reims, France; LPN EA2027 université Paris VIII, UFR psychologie, 2, rue de la Liberté, 93526 Saint-Denis cedex, France. Electronic address: atourbah@chu-reims.fr.
authors.forename: A
authors.initials: A
authors.lastname: Tourbah
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018450:Disease Progression; D005260:Female; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D000069442:Natalizumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab